JP2021529203A5 - - Google Patents

Info

Publication number
JP2021529203A5
JP2021529203A5 JP2020573396A JP2020573396A JP2021529203A5 JP 2021529203 A5 JP2021529203 A5 JP 2021529203A5 JP 2020573396 A JP2020573396 A JP 2020573396A JP 2020573396 A JP2020573396 A JP 2020573396A JP 2021529203 A5 JP2021529203 A5 JP 2021529203A5
Authority
JP
Japan
Prior art keywords
group
formula
compound according
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
JP2020573396A
Other languages
English (en)
Japanese (ja)
Other versions
JP7399898B2 (ja
JP2021529203A (ja
JPWO2020007938A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/067899 external-priority patent/WO2020007938A1/en
Publication of JP2021529203A publication Critical patent/JP2021529203A/ja
Publication of JP2021529203A5 publication Critical patent/JP2021529203A5/ja
Publication of JPWO2020007938A5 publication Critical patent/JPWO2020007938A5/ja
Application granted granted Critical
Publication of JP7399898B2 publication Critical patent/JP7399898B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020573396A 2018-07-03 2019-07-03 PqsRインバースアゴニスト Active JP7399898B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18181475 2018-07-03
EP18181475.7 2018-07-03
PCT/EP2019/067899 WO2020007938A1 (en) 2018-07-03 2019-07-03 PqsR INVERSE AGONISTS

Publications (4)

Publication Number Publication Date
JP2021529203A JP2021529203A (ja) 2021-10-28
JP2021529203A5 true JP2021529203A5 (https=) 2022-07-04
JPWO2020007938A5 JPWO2020007938A5 (https=) 2022-07-04
JP7399898B2 JP7399898B2 (ja) 2023-12-18

Family

ID=62846069

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020573396A Active JP7399898B2 (ja) 2018-07-03 2019-07-03 PqsRインバースアゴニスト

Country Status (6)

Country Link
US (1) US11883387B2 (https=)
EP (1) EP3818045A1 (https=)
JP (1) JP7399898B2 (https=)
AU (1) AU2019297409B2 (https=)
CA (1) CA3103351A1 (https=)
WO (1) WO2020007938A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3164264A1 (en) * 2020-01-02 2021-07-08 Helmholtz-Zentrum Fur Infektionsforschung Gmbh Novel pqsr inverse agonists
US12528783B2 (en) 2020-01-02 2026-01-20 Helmholtz-Zentrum Fur Infektionsforschung Gmbh PqsR inverse agonists
WO2024186827A2 (en) * 2023-03-06 2024-09-12 The Regents Of The University Of California Novel host-directed therapeutic agent for the treatment of infectious diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877940B2 (en) 2011-02-22 2014-11-04 Institut National De La Recherche Scientifique Antibiotic tolerance inhibitors
US9643933B2 (en) 2013-04-23 2017-05-09 The General Hospital Corporation Compounds useful as antibiotic tolerance inhibitors
WO2016007837A1 (en) 2014-07-11 2016-01-14 Spero Therapeutics, Inc. Carbonyl linked bicyclic heteroaryl antibiotic tolerance inhibitors
WO2016040764A1 (en) 2014-09-12 2016-03-17 Spero Therapeutics, Inc. Carbonyl linked bicyclic heteroaryl n-benzimidazoles and analogs as antibiotic tolerance inhibitors
WO2016112088A1 (en) 2015-01-06 2016-07-14 Spero Therapeutics, Inc. Aryloxyacetylindoles and analogs as antibiotic tolerance inhibitors
BR112018016329A2 (pt) 2016-02-10 2018-12-18 Janssen Pharmaceutica Nv 1,2,3-triazóis substituídos como moduladores de nmda seletivos para nr2b
CN108003151B (zh) * 2016-10-27 2019-11-05 湖南化工研究院有限公司 N-杂芳基甲基嘧啶胺类化合物及其制备方法与应用

Similar Documents

Publication Publication Date Title
JP2018531218A5 (https=)
JP2014503574A5 (https=)
JP2021529203A5 (https=)
JPWO2022138987A5 (https=)
JP2019524883A5 (https=)
JP2014503525A5 (https=)
JP2005523922A5 (https=)
JP2010540508A5 (https=)
JPWO2023099592A5 (https=)
JP2011518811A5 (https=)
JP2013542267A5 (https=)
JP2014500265A5 (https=)
JP2020500869A5 (https=)
JP2017504635A5 (https=)
JP2018168191A5 (https=)
JP2017504595A5 (https=)
TWI455938B (zh) 碳酸啶衍生物及其醫藥組成物
JP2007522162A5 (https=)
JP2007532627A5 (https=)
RU2010113358A (ru) Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов
JP2018529657A5 (https=)
JPWO2021030555A5 (https=)
JP2020111571A5 (https=)
JP2005500370A5 (https=)
JP2018527324A5 (https=)